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Abstract
Aims—To define outcome measures for
auditing the clinical care of children and
adolescents with insulin dependent
diabetes mellitus (IDDM) and to assess
the benefit of appointing a dedicated pae-
diatric trained diabetes specialist nurse
(PDSN).
Methods—Retrospective analysis of medi-
cal notes and hospital records. Glycaemic
control, growth, weight gain, microvascu-
lar complications, school absence, and the
proportion of children undergoing an
annual clinical review and diabetes educa-
tion session were assessed. The eVect of
the appointment of a PDSN on the
frequency of hospital admission, length of
inpatient stay, and outpatient attendance
was evaluated.
Results—Children with IDDM were of
normal height and grew well for three
years after diagnosis, but grew subopti-
mally thereafter. Weight gain was above
average every year after diagnosis. Gly-
caemic control was poor at all ages with
only 16% of children having an acceptable
glycated haemoglobin. Eighty five per cent
of patients underwent a formal annual
clinical review, of whom 16% had back-
ground retinopathy and 20% micro-
albuminuria in one or more samples.
After appointing the PDSN the median
length of hospital stay for newly diagnosed
patients decreased from five days to one
day, with 10 of 24 children not admitted.
None of the latter was admitted during the
next year. There was no evidence of the
PDSN aVecting the frequency of readmis-
sion or length of stay of children with
established IDDM. Non-attendance at the
outpatient clinic was reduced from a
median of 19 to 10%.
Conclusions—Outcome measures for
evaluating the care of children with IDDM
can be defined and evaluated. Specialist
nursing support markedly reduces the
length of hospital stay of newly diagnosed
patients without sacrificing the quality of
care.
(Arch Dis Child 1997;77:109–114)
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In recent years formalised audits have been
widely introduced in all sections of the UK
National Health Service. In clinical medicine,
outcome measures provide clinicians with
information about their practice which can be
used to improve the delivery of patient care. In
1989 the World Health Organisation and the
International Diabetes Federation produced
the St Vincent declaration.1 This highlighted
recommendations for standards of diabetes
care, and five year targets were set for the pro-
vision of resources, ensuring the rights and
responsibilities of patients, improved educa-
tion, and a reduction in complications.
In Wales, the Welsh OYce has produced rec-
ommendations for providing diabetes care.2
These recommendations use ‘outcome meas-
ures’ which relate to the process of patient
education and annual review. They do not refer
to the particular needs of children for whom
outcome measures such as growth, school
attendance, hospital admissions, clinic attend-
ance, and glycaemic control can be used to
improve patient care.
In April 1995 a dedicated paediatric trained
diabetes specialist nurse (PDSN) was ap-
pointed at the University Hospital of Wales to
provide education, advice, and practical sup-
port. One aim of this appointment was to
enable children with newly diagnosed insulin
dependent diabetes mellitus (IDDM) to start
treatment at home and to facilitate early
discharge of those requiring admission. Before
this appointment the paediatric diabetes clinic
was served by four part time diabetes nurses
who worked predominantly within the adult
service, most of whom had no paediatric train-
ing. These nurses were community based and
were not allowed to oVer a service to paediatric
inpatients or outside normal working hours.
The aim of this study was to define usable
outcome measures for auditing the clinical care
of children with IDDM and to assess the effect
of the first year of the appointment of the
PDSN.
Subjects and methods
The paediatric diabetes clinic at the University
Hospital of Wales provides diabetes care for
children predominantly within CardiV and the
Vale of Glamorgan (total population 425 800,
with 147 000 aged 15 years or younger), but
also serves a small proportion of the lower
Rhymney, Rhondda, Cynon, and TaV valleys.
At the time of the audit there were 154 children
(81 girls and 73 boys) receiving diabetes care at
the hospital. Sixteen children were less than 5
years old and 104 were older than 11. Children
are usually followed up in the clinic until 18
years of age. The median (range) duration of
diabetes was 12.5 (0.1–17.2) years.
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Data on clinic attendance and glycaemic
control were routinely collected and entered
onto a computerised database developed by Dr
K Robertson (Yorkhill Hospital, Glasgow)
adapted for local use. Statistical analysis was
carried out by appropriate parametric and
non-parametric statistical methods using SPSS
for Windows version 6.0.
At the end of 1993, after a previous audit, the
following standards were set for local diabetes
care: all children to have an annual review;
annual screening for complications and known
associations of IDDM; school attendance to be
documented; growth to be assessed every three
months; glycaemic control to be measured
every three months; children to attend outpa-
tient clinic every three months; initiation of
treatment for children with newly diagnosed
IDDM to be undertaken at home where
appropriate; and all children to undergo
continuing education.
This audit was carried out two years after
these standards were set to see if they had been
achieved. The audit was subdivided to evaluate
outcome measures for auditing clinical care
(data collected January 1996) and to evaluate
the eVect of the appointment of a dedicated
PDSN on hospital outpatient and inpatient
attendance and on patient education. Data
were collected on hospital outpatient and inpa-
tient attendance for the two years before (1
April 1993–31 March 1995) and compared
with the results for the first year after (1 April
1995–31 March 1996) the appointment of the
PDSN.
OUTCOME MEASURES OF CLINICAL CARE
Annual review
We intended all children with IDDM for one
year or more to undergo an annual review. One
hundred and twenty nine children (84%) were
eligible. A full examination was to be carried
out including assessment of the hands, feet,
and mouth, and the measurement of blood
pressure and palpation of peripheral pulses.
Pubertal development was to be assessed
according to the method of Tanner.3 A limited
neurological examination included testing for
abnormalities of vibration and pinprick sensa-
tion and tendon reflexes. The results of the
annual review were collected by retrospective
analysis of the medical notes.
Complications and associated problems
Children with IDDM older than 10 years or
who were five years or more from diagnosis
were screened for complications of retinopathy
and nephropathy. Eighty seven children (66%)
were eligible. Retinopathy was detected by
fundoscopy through a dilated pupil and by
retinal photography. Retinal photographs were
graded for evidence of retinopathy based on the
Welsh Community Diabetic Retinopathy
Study, a modification of the EURODIAB
grading.4 Abnormalities on either fundoscopy
or retinal photography were taken as positive
results. Screening for nephropathy was under-
taken by collecting three early morning urine
samples for the determination of micro-
albuminuria (assayed by nephelometry using
the Beckman Array system). Urinary albumin
excretion greater than 20 mg/l in one or more
samples was taken as indicating possible
significant microalbuminuria requiring further
evaluation.
The prevalence of thyroid disease, coeliac
disease, and hyperlipidaemia was assessed by
measuring free thyroxine, thyroid stimulating
hormone (assayed by automated chemilumi-
nescence using the Chiron Diagnostics system;
normal range free thyroxine 12–28 pmol/l, thy-
roid stimulating hormone <4.2 mU/l), total
IgA and IgA antigliadin antibodies (assayed by
sandwich immunoassay using the Pharmacia
CAP system; reference range 0–3 mg
antibody/l) and cholesterol and triglycerides
(assayed by enzymatic colorimetric test using
Sys 3 BM/Hitachi 747 system; reference range
for cholesterol <5.5 mmol/l and triglycerides
0.6–2.0 mmol/l).
School attendance
The documentation and extent of school
attendance over the preceding three months
was noted retrospectively from the medical
records.
Growth
Height was measured by a trained auxologist
using a wall mounted Harpenden stadiometer
(Holtain Ltd,Crymych,Dyfed) and weight was
measured using an Avery beam balance (Avery
Ltd, Birmingham). Measurements were ex-
pressed as SD scores. Weight was also cor-
rected for height (WFH%).5 6 Measurements
were taken from the first clinic visit after diag-
nosis to account for the eVects of dehydration
at clinical presentation and thereafter were col-
lected for the first seven years from diagnosis.
Glycaemic control
Glycaemic control was determined by the per-
centage glycated haemoglobin levels (% HbA1)
(assayed by gel electrophoresis using the Corn-
ing Glytrac method). The normal reference
range for HbA1 concentrations for the non-
diabetic population is 5.6–8.0 (mean (SD) 6.8
(0.6)%). Results less than 10% for children
with IDDM (5 SD above the mean non-
diabetic reference level) were taken to indicate
satisfactory glycaemic control. Insulin dosage
in units per kilogram body weight (U/kg) was
noted for each patient
NON-CLINICAL OUTCOME MEASURES TO
EVALUATE THE IMPACT OF THE PDSN
Clinic attendance
Non-attendance rates at the diabetes outpa-
tient clinics were collected retrospectively over
a three year period, two years before and one
year after the appointment of the PDSN. The
Table 1 Screening for complications and associated problems in children with IDDM;
values are number (%) of patients
Eligible for screening Actually screened Abnormalities detected
Retinopathy 87 (66) 78 (90) 12 (16)
Microalbuminuria 87 (66) 61 (70) 12 (20)
Thyroid function 154 (100) 109 (71) 2 (2)
Antigliadin antibody 154 (100) 109 (71) 4 (4)
Hyperlipidaemia 154 (100) 109 (71) 6 (5)
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younger children attend a morning paediatric
clinic (105 children), whereas children older
than 14 years (49 children) are encouraged to
attend an evening adolescent clinic held jointly
by doctors specialising in paediatric and adult
care. As a result of personal circumstances and
preferences not all these children attend the
adolescent clinic. Since the appointment of the
PDSN in 1995, eVorts have been made to
improve clinic attendance and in the second six
months after the appointment, clinic reminder
cards were sent to all children one week before
their outpatient appointment.
Hospital admissions
The number of admissions and length of
hospital stay were collected retrospectively for
children with newly diagnosed and established
IDDM. Data were collected over three years,
two years before and one year after the
appointment of the PDSN. Reasons for admis-
sions were noted.
Education
Diabetic education proformas are held by the
PDSN and evidence of continuing education
was expected for all children and adolescents.
The education proforma covers all aspects of
diabetes, including the nature of the disease,
dietary advice, monitoring, hypo/
hyperglycaemia, illness, exercise, complica-
tions, and social aspects.
Results
OUTCOME MEASURES OF CLINICAL CARE
Annual review
One hundred and ten patients (85%) had
undergone an annual review, most within the
12 months before the audit. Nineteen (15%)
had never had an annual review. Of those who
had been reviewed, all had their growth meas-
ured, but other data were incomplete in 19
(17%). In half there was no comment in the
notes about injection sites and one third had no
documented neurological examination. Four
(3%) had increased blood pressure with one
receiving treatment for hypertension. One
patient had reduced vibration and pinprick
sensation.
Complications and associated problems
Table 1 gives the results of the screening inves-
tigations. All the children identified with retin-
opathy had background retinopathy only
(grade 1, that is few microaneurysms, exu-
dates, or small haemorrhages outside the
macula). No child was detected with prolifera-
tive retinopathy. Two children with abnormal
thyroid function were detected: one child with
subclinical autoimmune hypothyroidism and
the other with hyperthyroidism. Four children
were noted to have increased levels of antiglia-
din antibodies, of which three were normal on
repeat investigation. The other child was
proved to have coeliac disease.
School attendance
School attendance had been documented in
110 (68%) of the medical notes. Four children
had missed more than one month of school
during the preceding three months. One had
cystic fibrosis and three were chronic school
refusers. All the other children had missed two
days or less.
Growth
Growth measurements were available for 122
children at diagnosis and 105 children for at
least one year after diagnosis. Long term
growth data were incomplete for 32 children,
mainly because of diagnosis elsewhere and
subsequent transfer to our unit. These children
were excluded from analysis. At diagnosis chil-
dren with IDDM were of normal height with a
mean (SD; range) height SD score of 0.15
(1.07; −3.50 to 2.90). Growth was normal for
the first three years after diagnosis, but
decreased thereafter (fig 1). Children were of
normal weight at diagnosis with a mean
Figure 1 Mean (SE) change in height SD score from diagnosis of IDDM; * p < 0.05
compared with diagnosis.
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Figure 2 Mean (SE) change in WFH% from diagnosis of IDDM; * p < 0.001
compared with diagnosis.
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%WFH of 102%. Weight increased signifi-
cantly in the seven years after diagnosis
(p < 0.001) (fig 2).
Glycaemic control
The mean (SD) percentage HbA1 for all
children was 12.5 (2.5). Children older than 11
years had a significantly higher mean (SD)
percentage HbA1 than those less than this age
(12.7 (2.5)% and 11.7 (2.1)%, respectively,
p < 0.05). A total of 129 children (84%) had an
HbA1 greater than 10%, higher than the ideal
target range (fig 3).
The mean dose of insulin was 0.8 U/kg
(range 0.1–2.0 U/kg). There was a significant
association between insulin dose and glycaemic
control; those treated with the highest doses of
insulin had the worst control (p < 0.05). There
was no relation between insulin dose and
growth or adiposity.
NON-CLINICAL OUTCOME MEASURES TO
EVALUATE THE IMPACT OF THE PDSN
Clinic attendance
Table 2 shows the attendance rates at clinics in
the two years before and one year after the
appointment of the specialist nurse. A signifi-
cant reduction in non-attendance rates was
seen in both clinics, but more notably in the
clinic for younger children.
Hospital admissions
In the two years before appointing the PDSN
the median (range) length of stay in hospital
after diagnosis was five (2–18) days, and after
the appointment one (0–7) day(s) (fig 4). Ten
of the 24 children presenting in the year after
the PDSN appointment did not need admis-
sion; before this appointment all children were
admitted after diagnosis. No child who started
insulin treatment at home was readmitted.
No change has yet been seen in the rate of
readmission or length of stay of children
diagnosed with IDDM before the appointment
of the PDSN. Twenty eight such children each
year require readmission, with a median (range)
length of stay of two (0.5–13) days. Most of
these admissions are due to ketoacidosis.
Education
All patients had an individual diabetic
educational proforma and 144 children (94%)
underwent continuing diabetic education ei-
ther at home or in the clinic.
Discussion
It has been suggested that the appropriate out-
come measures in contracting for diabetes care
should be that patient education is continuing
and that patients undergo an annual review.2
These processes, rather than outcome meas-
ures, have been recommended because other
variables, such as those used in this study, may
not reflect the contracting process as they are
not directly under the control of doctors but
require patient cooperation. However, patient
compliance may partly be a measure of the
success of education and therefore we believe
that growth, glycaemic control, hospital admis-
sion, and clinic visits are valid outcome
measures for audit.
This study has shown, along with others,7
that children grow well in the first three years
after diagnosis, but thereafter growth deterio-
rates. It is postulated that this may be due to a
blunting or delay in the pubertal growth spurt
which is known to occur, particularly in
diabetic girls. In our audit specific details on
stages of puberty were not collected so we can-
not comment on whether pubertal delay may
be contributing to the reduction in height SD
scores with time from diagnosis. The fall oV in
growth did not appear to be a temporary phe-
nomenon, however, as would be expected if
delayed puberty were the cause, as the children
who had reached final height had a mean (SD;
range) final height SD score of −0.54 (1.2;
−3.5 to 1.2). It might be expected that children
grow well initially from diagnosis due to the
anabolic eVects of insulin in those who were
previously insulin deficient. The fall oV in
growth three years from diagnosis may reflect
the influence of deteriorating glycaemic control
in that poor control is known to be associated
Figure 3 Distribution of percentage HbA1 results.
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Table 2 Median (range) non-attendance rates (%) at the
diabetes clinic
Year Paediatric clinic Adolescent clinic
1 21 (0–42) 31 (12–55)
2 19 (0–44) 38 (25–59)
3† 10 (0–43)* 23 (7–56)**
† After appointment of PDSN.
* p < 0.001; ** p < 0.05 for year 3 compared with years 1 and
2.
Figure 4 Length of hospital stay for patients with newly
diagnosed IDDM in relation to the appointment of a
PDSN; * p < 0.001.
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with poor growth.7–9 The continued excess
weight gain observed in this study is of concern
as a risk factor for the later development of
ischaemic heart disease and possibly diabetic
retinopathy.10
The Diabetes Control and Complications
Trial has shown that improved glycaemic con-
trol has a notable benefit in reducing the com-
plications of IDDM.11 Microvascular compli-
cations are rarely seen in prepubertal children,
hence the restriction of our screening to
children over 10 years of age or with IDDM for
more than five years. Complications are known
to be related to poor long term glycaemic
control.12 Although glycated haemoglobin con-
centrations less than 4 SD above the mean
laboratory specific reference levels have been
taken to indicate satisfactory glycaemic
control,13 there is debate regarding this. The
British Diabetic Association has recommended
aiming for much tighter control.14 At the time
of our audit we took HbA1 concentrations less
than 10% to indicate satisfactory control,
which equates to values within 5 SD of the
mean non-diabetic reference range. Glycaemic
control was worse for children older than 11
years, adolescence being a notoriously diYcult
age at which to achieve good control.15 The
results for our clinic were disappointing and
indicated poor glycaemic control overall com-
pared with the target, with 84% of the children
having HbA1 values greater than 10%. This
might suggest that the ‘ideal’ target value is
unrealistic and comparative studies between
diVerent clinics would help clarify this.
Nevertheless, the finding of background dia-
betic retinopathy in 16% of children in our
clinic suggests a measurable consequence of
poor glycaemic control. This finding also con-
firms the importance of a detailed skilled
retinal examination by appropriately trained
staV. Others have also described a high
incidence of background retinopathy after
detailed examination.16
Few associated problems of IDDM were
detected at the annual review. One child was
diagnosed with coeliac disease, identified by
positive antigliadin antibodies and confirmed
by taking a jejunal biopsy sample. Detecting six
children with hyperlipidaemia allowed dietary
advice to be given with the aim of reducing the
impact of this risk factor on later cardiovascular
complications.
We took a urinary albumin excretion of
greater than 20 mg/l in one sample to represent
possible microalbuminuria. This might be
considered a low threshold and could give rise
to an artificially high rate of microalbuminuria
in our clinic. Positive screening stimulated fur-
ther investigation of the patients identified, ini-
tially by collecting a further three urine
samples. Although this is non-invasive we
accept that it might cause unnecessary anxiety
and taking a positive result in two samples
rather than just one might be preferable.We are
concerned that one third of children did not
have a documented neurological examination.
Others have found a significant number of
children to have evidence of subclinical neu-
ropathy and if no appropriate examination is
carried out these will be missed.17 18
The appointment of a dedicated PDSN
might have been expected to improve educa-
tion, clinic attendance, and hospital admis-
sions, these being the main aims. The PDSN
has a major role in the continuing education of
the children with IDDM and their families and
there is growing evidence that eVective educa-
tion programmes can reduce complications.19
One year after this appointment we have shown
improvements in care. The non-attendance
rate at clinic visits for the children’s clinic
improved from 19 to 10% and for the
adolescent clinic from 38 to 23%. This is not
unexpected as adolescents with IDDM are
more diYcult to motivate. The most notable
eVect of the appointment of the specialist nurse
has been to reduce the admission rates and
length of stay for newly diagnosed patients with
IDDM. Thus the median hospital stay at diag-
nosis has fallen from five days to one day, with
10 children requiring no admission. None of
these children subsequently required readmis-
sion in the year after the appointment. Before
the PDSN appointment all children were
admitted at diagnosis. There was no diVerence
in the ages of the children diagnosed with
IDDM in the two years before and the year
after the appointment of the PDSN. In keeping
with others20 we have met no adverse eVects of
this early discharge and the children and their
parents have all expressed satisfaction. There
are considerable advantages in initial home
based management: the distress of admission is
avoided and the child and parents are often
more at ease. So far the PDSN has had no
eVect on admissions of children with estab-
lished diabetes, but this might be expected to
take longer as established views and behaviour
are less amenable to change.
Recommendations
This audit of paediatric diabetes care has led to
several recommendations and targets for the
next three years to improve outcome.
x Continue annual review: 90% of eligible
children within any 12 month period and
documentation of inspection of injection sites
and neurological examination to be improved
to 100%
x Reduce adolescent outpatient non-
attendance to 10%
x Improve glycaemic control: 2% improve-
ment in HbA1 across the clinic population
x Retinopathy and microalbuminuria
screening to continue: improve microalbumin-
uria screening to 90% of those eligible and
maintain retinopathy screening at 90%
x Reduce prevalence of microalbuminuria by
one third to 14%
x Reduce prevalence of retinopathy by one
third to 12%
x Continue annual measurement of serum
lipids and referral to dieticians of all those sub-
jects with abnormally high concentrations
x Reduce by one third readmissions of chil-
dren with IDDM.
We intend to use the dedicated PDSN further
to help achieve these recommendations. A 24
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hour telephone advice service has been set up to
deal with alterations in insulin treatment and
give general advice on diabetic management.We
hope that this instant response service will
enable children whom we currently admit when
unwell to be managed at home. Reminders of
imminent clinic appointments will be sent to
attempt to reduce non-attendance rates. Im-
proving glycaemic control remains the greatest
challenge. We need to convince our teenagers,
through targeted education, that better control
will be beneficial in the long term.With this aim
we are setting up age banded education sessions.
The PDSN will make home visits to follow up
poor HbA1 results and give personal advice on
how improvements can be made. This will
enable closer monitoring than simply giving
advice at clinic visits every three months. If
improvements in control can be achieved, then
we would expect the frequency of complications
to be reduced. Emphasis on the importance of
the annual review will be given to the clinic doc-
tors to achieve our aim of a 90% uptake.
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